Colgate-Palmolive (CL) Shares Sold by FDO Partners LLC
FDO Partners LLC cut its position in shares of Colgate-Palmolive (NYSE:CL) by 86.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,893 shares of the company’s stock after selling 17,815 shares during the period. FDO Partners LLC’s holdings in Colgate-Palmolive were worth $211,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Pacer Advisors Inc. increased its holdings in shares of Colgate-Palmolive by 8.4% in the 2nd quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock valued at $1,499,000 after acquiring an additional 1,566 shares during the period. Fiduciary Trust Co. increased its holdings in shares of Colgate-Palmolive by 1.6% in the 2nd quarter. Fiduciary Trust Co. now owns 170,818 shares of the company’s stock valued at $12,663,000 after acquiring an additional 2,758 shares during the period. The Manufacturers Life Insurance Company increased its holdings in shares of Colgate-Palmolive by 10.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock valued at $83,914,000 after acquiring an additional 105,878 shares during the period. Pensionfund DSM Netherlands purchased a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $4,225,000. Finally, Pacad Investment Ltd. purchased a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $549,000. 72.86% of the stock is owned by institutional investors and hedge funds.
CL has been the topic of several research analyst reports. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $84.00 target price on the stock in a research note on Monday, January 8th. Jefferies Group restated a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a research note on Thursday, September 28th. Royal Bank of Canada restated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Citigroup dropped their target price on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research note on Thursday, November 2nd. Finally, KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $76.51.
In other news, CMO Mukul Deoras sold 7,500 shares of the business’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the completion of the transaction, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Victoria L. Dolan sold 10,000 shares of the business’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the completion of the transaction, the insider now directly owns 60,528 shares of the company’s stock, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. In the last quarter, insiders have sold 181,950 shares of company stock worth $13,237,385. Company insiders own 1.02% of the company’s stock.
Shares of Colgate-Palmolive (CL) opened at $74.62 on Monday. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The firm has a market capitalization of $65,524.21, a PE ratio of 26.00, a price-to-earnings-growth ratio of 3.15 and a beta of 0.80. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.73. The business had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.73 EPS. equities research analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s payout ratio is presently 61.78%.
TRADEMARK VIOLATION NOTICE: “Colgate-Palmolive (CL) Shares Sold by FDO Partners LLC” was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.watchlistnews.com/colgate-palmolive-cl-shares-sold-by-fdo-partners-llc/1807768.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.